Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Foramen Ovale, Patent | 12 | 2021 | 210 | 4.040 |
Why?
|
Stroke | 32 | 2024 | 9755 | 1.940 |
Why?
|
Thrombophilia | 3 | 2021 | 308 | 1.200 |
Why?
|
Subarachnoid Hemorrhage | 7 | 2021 | 1024 | 1.070 |
Why?
|
Embolism, Paradoxical | 3 | 2021 | 55 | 0.930 |
Why?
|
Gelsolin | 2 | 2014 | 189 | 0.790 |
Why?
|
Proteomics | 7 | 2017 | 3912 | 0.740 |
Why?
|
Ischemic Attack, Transient | 7 | 2021 | 877 | 0.730 |
Why?
|
Hemorrhagic Disorders | 2 | 2012 | 34 | 0.670 |
Why?
|
Atrial Appendage | 1 | 2023 | 285 | 0.660 |
Why?
|
Heart Arrest | 3 | 2023 | 1516 | 0.600 |
Why?
|
Glycoproteins | 2 | 2017 | 2202 | 0.570 |
Why?
|
Embolism | 1 | 2020 | 401 | 0.560 |
Why?
|
Tissue Plasminogen Activator | 8 | 2022 | 1165 | 0.470 |
Why?
|
Brain Ischemia | 9 | 2024 | 3007 | 0.470 |
Why?
|
Hypothermia, Induced | 2 | 2017 | 754 | 0.470 |
Why?
|
Vertebral Artery Dissection | 1 | 2013 | 48 | 0.430 |
Why?
|
Blood-Brain Barrier | 3 | 2024 | 1034 | 0.430 |
Why?
|
Mass Spectrometry | 4 | 2021 | 2202 | 0.420 |
Why?
|
Biomarkers, Pharmacological | 1 | 2013 | 162 | 0.400 |
Why?
|
Molecular Probe Techniques | 1 | 2013 | 111 | 0.400 |
Why?
|
Matrix Metalloproteinase 9 | 5 | 2011 | 633 | 0.370 |
Why?
|
Lectins | 1 | 2013 | 490 | 0.360 |
Why?
|
Migraine Disorders | 5 | 2020 | 1713 | 0.340 |
Why?
|
Nervous System Diseases | 3 | 2019 | 1662 | 0.340 |
Why?
|
Apolipoproteins | 1 | 2012 | 328 | 0.340 |
Why?
|
Endothelial Cells | 6 | 2024 | 3589 | 0.330 |
Why?
|
Cerebral Infarction | 2 | 2013 | 969 | 0.320 |
Why?
|
ROC Curve | 2 | 2017 | 3628 | 0.310 |
Why?
|
Brain | 15 | 2022 | 27360 | 0.300 |
Why?
|
Apolipoproteins E | 1 | 2014 | 1461 | 0.300 |
Why?
|
Blood Proteins | 3 | 2012 | 1191 | 0.300 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2011 | 452 | 0.280 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2016 | 4352 | 0.280 |
Why?
|
Microglia | 4 | 2020 | 1376 | 0.280 |
Why?
|
Brain Edema | 1 | 2011 | 601 | 0.270 |
Why?
|
Recurrence | 6 | 2021 | 8509 | 0.270 |
Why?
|
Thrombolytic Therapy | 7 | 2022 | 2055 | 0.270 |
Why?
|
Fibrinolytic Agents | 6 | 2022 | 2080 | 0.260 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 1197 | 0.260 |
Why?
|
Endothelium, Vascular | 3 | 2018 | 4427 | 0.260 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2006 | 149 | 0.260 |
Why?
|
Peptide Hydrolases | 1 | 2009 | 610 | 0.260 |
Why?
|
Cerebrovascular Disorders | 1 | 2012 | 1485 | 0.250 |
Why?
|
Treatment Outcome | 15 | 2023 | 65371 | 0.250 |
Why?
|
Proteome | 3 | 2012 | 1890 | 0.240 |
Why?
|
Neurodegenerative Diseases | 1 | 2014 | 1095 | 0.240 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 2005 | 68 | 0.230 |
Why?
|
Oxidative Stress | 3 | 2010 | 3139 | 0.230 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5176 | 0.230 |
Why?
|
Septal Occluder Device | 3 | 2020 | 126 | 0.230 |
Why?
|
Intracranial Aneurysm | 1 | 2014 | 1271 | 0.220 |
Why?
|
Blood Vessels | 1 | 2009 | 1110 | 0.210 |
Why?
|
Reperfusion Injury | 1 | 2009 | 1039 | 0.200 |
Why?
|
Pregnancy Complications | 1 | 2016 | 2973 | 0.190 |
Why?
|
Humans | 62 | 2024 | 768166 | 0.190 |
Why?
|
Tight Junctions | 1 | 2024 | 324 | 0.190 |
Why?
|
Sinus Thrombosis, Intracranial | 2 | 2013 | 111 | 0.190 |
Why?
|
Streptococcal Infections | 1 | 2005 | 619 | 0.180 |
Why?
|
Influenza, Human | 1 | 2011 | 1541 | 0.170 |
Why?
|
Signal Transduction | 3 | 2013 | 23645 | 0.170 |
Why?
|
Coma | 1 | 2023 | 485 | 0.170 |
Why?
|
Male | 41 | 2024 | 364719 | 0.160 |
Why?
|
Cerebral Amyloid Angiopathy | 2 | 2022 | 887 | 0.150 |
Why?
|
Brain Death | 1 | 2001 | 359 | 0.150 |
Why?
|
Spinal Injuries | 1 | 2001 | 300 | 0.150 |
Why?
|
Inflammation Mediators | 2 | 2021 | 1892 | 0.150 |
Why?
|
Homocysteine | 1 | 2021 | 637 | 0.150 |
Why?
|
Alzheimer Disease | 2 | 2022 | 8759 | 0.150 |
Why?
|
Ceruloplasmin | 1 | 2017 | 57 | 0.140 |
Why?
|
Annexin A2 | 1 | 2017 | 43 | 0.140 |
Why?
|
Echocardiography | 2 | 2020 | 5047 | 0.130 |
Why?
|
Female | 31 | 2024 | 397192 | 0.130 |
Why?
|
Anticoagulants | 2 | 2023 | 4852 | 0.130 |
Why?
|
Secondary Prevention | 2 | 2020 | 1474 | 0.130 |
Why?
|
Algorithms | 2 | 2019 | 14164 | 0.130 |
Why?
|
Haptoglobins | 1 | 2017 | 165 | 0.130 |
Why?
|
Middle Aged | 23 | 2024 | 223492 | 0.130 |
Why?
|
Extracellular Fluid | 1 | 2017 | 165 | 0.130 |
Why?
|
Extracellular Space | 1 | 2018 | 563 | 0.130 |
Why?
|
Intracranial Embolism | 2 | 2017 | 188 | 0.130 |
Why?
|
Central Nervous System Diseases | 2 | 2018 | 520 | 0.130 |
Why?
|
Gene Expression Regulation | 2 | 2012 | 11928 | 0.120 |
Why?
|
Prospective Studies | 8 | 2024 | 54926 | 0.120 |
Why?
|
Oxygen | 2 | 2018 | 4270 | 0.120 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2024 | 1751 | 0.120 |
Why?
|
Glucose | 2 | 2018 | 4352 | 0.120 |
Why?
|
Cervical Vertebrae | 1 | 2001 | 979 | 0.120 |
Why?
|
Cadherins | 1 | 2020 | 905 | 0.120 |
Why?
|
Endocarditis | 1 | 2019 | 352 | 0.120 |
Why?
|
Magnetic Resonance Angiography | 3 | 2013 | 1429 | 0.120 |
Why?
|
Neurologic Examination | 1 | 2017 | 914 | 0.110 |
Why?
|
Diagnostic Errors | 1 | 2001 | 1281 | 0.110 |
Why?
|
Mitochondria | 2 | 2018 | 3681 | 0.110 |
Why?
|
Spinal Cord Injuries | 1 | 2001 | 928 | 0.110 |
Why?
|
Coronary Circulation | 1 | 2020 | 1617 | 0.110 |
Why?
|
Intracranial Hemorrhages | 1 | 2019 | 810 | 0.110 |
Why?
|
Adult | 18 | 2021 | 223646 | 0.110 |
Why?
|
Astrocytes | 2 | 2018 | 1350 | 0.100 |
Why?
|
Prognosis | 9 | 2024 | 30010 | 0.100 |
Why?
|
Animals | 23 | 2024 | 169246 | 0.100 |
Why?
|
Polyvinyls | 1 | 2013 | 154 | 0.100 |
Why?
|
Recovery of Function | 3 | 2020 | 2981 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2020 | 1388 | 0.100 |
Why?
|
Endothelin-1 | 1 | 2013 | 296 | 0.100 |
Why?
|
Cardiomyopathies | 1 | 2024 | 2056 | 0.100 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1030 | 0.100 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2013 | 308 | 0.100 |
Why?
|
Metalloendopeptidases | 1 | 2013 | 386 | 0.090 |
Why?
|
Chemokines | 1 | 2016 | 963 | 0.090 |
Why?
|
Limit of Detection | 1 | 2012 | 277 | 0.090 |
Why?
|
Membranes, Artificial | 1 | 2013 | 367 | 0.090 |
Why?
|
Aged | 16 | 2024 | 171504 | 0.090 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2013 | 425 | 0.090 |
Why?
|
Cell Communication | 1 | 2018 | 1660 | 0.090 |
Why?
|
Brain Injuries | 1 | 2022 | 2057 | 0.090 |
Why?
|
Interleukins | 1 | 2016 | 796 | 0.090 |
Why?
|
Papilledema | 1 | 2012 | 130 | 0.090 |
Why?
|
Dizziness | 1 | 2013 | 269 | 0.090 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 1730 | 0.090 |
Why?
|
Dipyridamole | 1 | 2010 | 143 | 0.090 |
Why?
|
Nerve Regeneration | 1 | 2016 | 797 | 0.090 |
Why?
|
Vomiting | 1 | 2013 | 655 | 0.090 |
Why?
|
Inflammation | 4 | 2022 | 10873 | 0.090 |
Why?
|
Free Radical Scavengers | 1 | 2010 | 213 | 0.080 |
Why?
|
Rats, Wistar | 3 | 2022 | 1888 | 0.080 |
Why?
|
Cytotoxins | 1 | 2010 | 154 | 0.080 |
Why?
|
Glycosylation | 1 | 2013 | 1100 | 0.080 |
Why?
|
Biomedical Technology | 1 | 2012 | 210 | 0.080 |
Why?
|
Circadian Rhythm | 1 | 2021 | 2593 | 0.080 |
Why?
|
Fibrinogen | 1 | 2013 | 891 | 0.080 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2010 | 213 | 0.080 |
Why?
|
Antigens, CD | 1 | 2020 | 4035 | 0.080 |
Why?
|
Protein Isoforms | 1 | 2014 | 1715 | 0.080 |
Why?
|
Chromatography, Liquid | 1 | 2012 | 996 | 0.080 |
Why?
|
Aspirin | 1 | 2020 | 3135 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 2763 | 0.080 |
Why?
|
Hydrocephalus | 2 | 2013 | 768 | 0.080 |
Why?
|
Cardiovascular Diseases | 1 | 2014 | 15662 | 0.070 |
Why?
|
F2-Isoprostanes | 1 | 2007 | 35 | 0.070 |
Why?
|
Rats | 6 | 2022 | 23760 | 0.070 |
Why?
|
Thrombospondin 1 | 1 | 2009 | 257 | 0.070 |
Why?
|
Time Factors | 7 | 2020 | 40218 | 0.070 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2008 | 141 | 0.070 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2012 | 1124 | 0.070 |
Why?
|
Pneumocephalus | 1 | 2006 | 46 | 0.070 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2006 | 87 | 0.070 |
Why?
|
Convalescence | 1 | 2006 | 107 | 0.060 |
Why?
|
Spinal Cord Diseases | 1 | 2008 | 291 | 0.060 |
Why?
|
Enzyme Induction | 1 | 2006 | 455 | 0.060 |
Why?
|
Heart Diseases | 1 | 2018 | 2819 | 0.060 |
Why?
|
Brain Damage, Chronic | 1 | 2006 | 265 | 0.060 |
Why?
|
Cerebral Hemorrhage | 3 | 2009 | 2655 | 0.060 |
Why?
|
Case-Control Studies | 4 | 2013 | 22291 | 0.060 |
Why?
|
Cerebral Arteries | 1 | 2007 | 488 | 0.060 |
Why?
|
Iatrogenic Disease | 1 | 2008 | 552 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1966 | 0.060 |
Why?
|
Prostatic Hyperplasia | 1 | 2008 | 516 | 0.060 |
Why?
|
Plasminogen Activators | 1 | 2004 | 199 | 0.060 |
Why?
|
Age Factors | 2 | 2016 | 18412 | 0.060 |
Why?
|
Organic Cation Transport Proteins | 1 | 2024 | 61 | 0.060 |
Why?
|
Mice, Inbred C57BL | 5 | 2024 | 22379 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2009 | 1169 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3251 | 0.060 |
Why?
|
Deoxyribonucleases | 1 | 2005 | 209 | 0.060 |
Why?
|
Leukocytosis | 1 | 2005 | 251 | 0.060 |
Why?
|
Phenotype | 2 | 2020 | 16726 | 0.050 |
Why?
|
Retinal Diseases | 2 | 2000 | 710 | 0.050 |
Why?
|
Methylprednisolone | 1 | 2005 | 386 | 0.050 |
Why?
|
Pharyngitis | 1 | 2005 | 222 | 0.050 |
Why?
|
Ischemia | 1 | 2012 | 1900 | 0.050 |
Why?
|
Aged, 80 and over | 6 | 2020 | 59629 | 0.050 |
Why?
|
Cell Death | 2 | 2024 | 1679 | 0.050 |
Why?
|
Epilepsy | 1 | 2018 | 3327 | 0.050 |
Why?
|
Drug Therapy, Combination | 3 | 2020 | 6316 | 0.050 |
Why?
|
Disease Models, Animal | 3 | 2022 | 18349 | 0.050 |
Why?
|
Eye Diseases | 1 | 2008 | 660 | 0.050 |
Why?
|
China | 2 | 2019 | 2395 | 0.050 |
Why?
|
Interleukin-6 | 1 | 2012 | 3228 | 0.050 |
Why?
|
Cell Hypoxia | 2 | 2018 | 662 | 0.050 |
Why?
|
Leukocyte Count | 1 | 2006 | 1609 | 0.050 |
Why?
|
Basal Ganglia | 1 | 2005 | 553 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5889 | 0.050 |
Why?
|
Echo-Planar Imaging | 1 | 2006 | 648 | 0.050 |
Why?
|
Cohort Studies | 3 | 2018 | 41754 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 1 | 2004 | 18065 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 3 | 2018 | 8128 | 0.050 |
Why?
|
Nitric Oxide | 1 | 2010 | 2146 | 0.050 |
Why?
|
Neurons | 2 | 2018 | 9514 | 0.050 |
Why?
|
Young Adult | 5 | 2020 | 60066 | 0.050 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2022 | 279 | 0.050 |
Why?
|
Risk Factors | 6 | 2024 | 74944 | 0.050 |
Why?
|
Contraceptives, Oral | 1 | 2004 | 560 | 0.050 |
Why?
|
Neostigmine | 1 | 2021 | 68 | 0.050 |
Why?
|
Nasal Polyps | 1 | 2006 | 412 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2013 | 13014 | 0.040 |
Why?
|
Molecular Sequence Data | 2 | 2012 | 17622 | 0.040 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2005 | 667 | 0.040 |
Why?
|
Vascular Diseases | 1 | 2009 | 1162 | 0.040 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 13421 | 0.040 |
Why?
|
Sulfur Hexafluoride | 1 | 2000 | 26 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2018 | 19015 | 0.040 |
Why?
|
Silicone Oils | 1 | 2000 | 22 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4413 | 0.040 |
Why?
|
Cell Line | 2 | 2010 | 15597 | 0.040 |
Why?
|
Glasgow Coma Scale | 1 | 2001 | 574 | 0.040 |
Why?
|
Mice | 7 | 2024 | 82029 | 0.040 |
Why?
|
Heart | 1 | 2012 | 4446 | 0.040 |
Why?
|
Air | 1 | 2000 | 187 | 0.040 |
Why?
|
Aging | 1 | 2018 | 8744 | 0.040 |
Why?
|
Pregnancy | 2 | 2016 | 30256 | 0.040 |
Why?
|
Brain Diseases | 1 | 2008 | 1554 | 0.040 |
Why?
|
Critical Care | 1 | 2012 | 2715 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 3814 | 0.040 |
Why?
|
Retina | 2 | 2000 | 2662 | 0.040 |
Why?
|
Aplysia | 1 | 1998 | 40 | 0.040 |
Why?
|
Cerebrospinal Fluid | 1 | 2021 | 540 | 0.040 |
Why?
|
Hypertension | 1 | 2018 | 8616 | 0.040 |
Why?
|
Insulin | 1 | 2012 | 6607 | 0.040 |
Why?
|
Heart Atria | 1 | 2024 | 1361 | 0.040 |
Why?
|
Reperfusion | 1 | 2018 | 266 | 0.040 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2010 | 693 | 0.040 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2022 | 1117 | 0.030 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 492 | 0.030 |
Why?
|
Long-Term Potentiation | 1 | 1998 | 290 | 0.030 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2018 | 277 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2017 | 297 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2010 | 1134 | 0.030 |
Why?
|
Research Design | 1 | 2012 | 6211 | 0.030 |
Why?
|
Neurosurgical Procedures | 1 | 2006 | 2076 | 0.030 |
Why?
|
Neurons, Afferent | 1 | 1998 | 498 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2005 | 1805 | 0.030 |
Why?
|
Acute Disease | 2 | 2018 | 7243 | 0.030 |
Why?
|
Substance Abuse, Intravenous | 1 | 2019 | 530 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 5 | 2023 | 36743 | 0.030 |
Why?
|
Fluorocarbons | 1 | 2000 | 506 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 12252 | 0.030 |
Why?
|
Microvessels | 1 | 2018 | 585 | 0.030 |
Why?
|
Neovascularization, Physiologic | 2 | 2012 | 1369 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2011 | 20760 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2020 | 2815 | 0.030 |
Why?
|
Capillary Permeability | 1 | 2017 | 772 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39348 | 0.030 |
Why?
|
Serotonin | 1 | 1998 | 1043 | 0.030 |
Why?
|
Bradykinin | 1 | 2013 | 205 | 0.030 |
Why?
|
Benzofurans | 1 | 2013 | 138 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2018 | 2678 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2018 | 1676 | 0.030 |
Why?
|
Neuroglia | 1 | 2018 | 960 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2018 | 958 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2007 | 15948 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2024 | 5151 | 0.020 |
Why?
|
Species Specificity | 1 | 2016 | 2415 | 0.020 |
Why?
|
Intracranial Thrombosis | 1 | 2012 | 109 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2019 | 15832 | 0.020 |
Why?
|
Databases, Protein | 1 | 2012 | 390 | 0.020 |
Why?
|
Glycemic Index | 1 | 2012 | 400 | 0.020 |
Why?
|
Survival Rate | 1 | 2024 | 12840 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2022 | 9561 | 0.020 |
Why?
|
Patient Selection | 2 | 2013 | 4260 | 0.020 |
Why?
|
Predictive Value of Tests | 3 | 2013 | 15454 | 0.020 |
Why?
|
Hospitals, General | 1 | 2013 | 809 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2019 | 2235 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2022 | 3914 | 0.020 |
Why?
|
Iliac Vein | 1 | 2009 | 71 | 0.020 |
Why?
|
Down-Regulation | 1 | 2016 | 2937 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2012 | 1104 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1667 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2010 | 461 | 0.020 |
Why?
|
Phlebography | 1 | 2009 | 326 | 0.020 |
Why?
|
Vitreous Body | 2 | 2000 | 401 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2017 | 6514 | 0.020 |
Why?
|
Posterior Cerebral Artery | 1 | 2007 | 35 | 0.020 |
Why?
|
alpha-Tocopherol | 1 | 2007 | 127 | 0.020 |
Why?
|
Neuroimmunomodulation | 1 | 2009 | 187 | 0.020 |
Why?
|
Anterior Cerebral Artery | 1 | 2007 | 50 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2004 | 4423 | 0.020 |
Why?
|
Heart Defects, Congenital | 1 | 2004 | 4712 | 0.020 |
Why?
|
Injections | 2 | 2000 | 840 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4146 | 0.020 |
Why?
|
Basilar Artery | 1 | 2007 | 207 | 0.020 |
Why?
|
Middle Cerebral Artery | 1 | 2007 | 271 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 2732 | 0.020 |
Why?
|
Hospitals | 1 | 2019 | 3886 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2020 | 81762 | 0.020 |
Why?
|
Myocardium | 1 | 2018 | 4788 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8054 | 0.020 |
Why?
|
Adolescent | 3 | 2020 | 89169 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2001 | 9015 | 0.010 |
Why?
|
Ascorbic Acid | 1 | 2007 | 658 | 0.010 |
Why?
|
Urinary Incontinence | 1 | 2008 | 490 | 0.010 |
Why?
|
Oligopeptides | 1 | 2009 | 1194 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13290 | 0.010 |
Why?
|
Sex Distribution | 1 | 2009 | 2278 | 0.010 |
Why?
|
Rabbits | 2 | 2000 | 4772 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7598 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6526 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2013 | 3728 | 0.010 |
Why?
|
Metabolomics | 1 | 2012 | 1674 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10399 | 0.010 |
Why?
|
Quality of Life | 1 | 2004 | 13490 | 0.010 |
Why?
|
Matrix Metalloproteinases | 1 | 2004 | 393 | 0.010 |
Why?
|
Syndrome | 1 | 2008 | 3272 | 0.010 |
Why?
|
Vasoconstriction | 1 | 2004 | 592 | 0.010 |
Why?
|
Clinical Protocols | 1 | 2007 | 1443 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15869 | 0.010 |
Why?
|
Boston | 1 | 2013 | 9374 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9343 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5777 | 0.010 |
Why?
|
Frontal Lobe | 1 | 2006 | 1426 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2007 | 1835 | 0.010 |
Why?
|
Antioxidants | 1 | 2007 | 1673 | 0.010 |
Why?
|
Blood Glucose | 1 | 2012 | 6430 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14729 | 0.010 |
Why?
|
Cell Movement | 1 | 2009 | 5210 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 26379 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2007 | 2008 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2000 | 1703 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2004 | 1738 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9538 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 1998 | 287 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 1998 | 478 | 0.010 |
Why?
|
Genomics | 1 | 2012 | 5926 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 1998 | 481 | 0.010 |
Why?
|
Safety | 1 | 2000 | 1159 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1998 | 1989 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2000 | 1191 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2009 | 14488 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1998 | 1751 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1998 | 2748 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1998 | 2179 | 0.010 |
Why?
|
Survivors | 1 | 2004 | 2381 | 0.010 |
Why?
|
Blood Pressure | 1 | 2008 | 8543 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1998 | 4168 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1998 | 3590 | 0.010 |
Why?
|
Incidence | 1 | 2009 | 21538 | 0.010 |
Why?
|
Phosphoproteins | 1 | 1998 | 2451 | 0.000 |
Why?
|
Base Sequence | 1 | 1998 | 12421 | 0.000 |
Why?
|
Nuclear Proteins | 1 | 1998 | 5804 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 1998 | 9615 | 0.000 |
Why?
|